Virtu KCG Holdings’s AstraZeneca AZN Stock Holding History

Virtu KCG Holdings’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,200	Closed	-$225K	–	3134
2014 Q4	$225K	Buy	+3,200	New	+$229K	﹤0.01%	2735
2014 Q3	–	Sell	-4,300	Closed	-$320K	–	3572
2014 Q2	$320K	Sell	4,300 -5,400	-56%	-$390K	0.01%	2474
2014 Q1	$629K	Buy	9,700 +5,100	+111%	+$329K	0.01%	1701
2013 Q4	$273K	Hold	4,600	–	–	﹤0.01%	2700
2013 Q3	$239K	Buy	+4,600	New	+$231K	﹤0.01%	2903

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Virtu KCG Holdings's AZN Position: Q2 2017 in Review

Virtu KCG Holdings increased its AstraZeneca (AZN) stake by 11% in Q2 2017, buying an estimated $111K and bringing the position to 17,412 shares worth $1.19M. The position accounts for 0.03% of the portfolio, ranked #483.

Virtu KCG Holdings first reported a position in AZN in Q3 2013 and has held it in 15 quarters since. The position peaked at $34.1M in Q4 2013. 465 funds tracked by Wall St. Rank hold AZN as of Q2 2017.

Virtu KCG Holdings held 17,412 shares of AstraZeneca worth $1.19M as of Q2 2017.
Virtu KCG Holdings bought 1,694 AstraZeneca shares in Q2 2017, an estimated $111K.
AstraZeneca made up 0.03% of Virtu KCG Holdings's portfolio in Q2 2017, its #483 holding.
Virtu KCG Holdings first reported a position in AstraZeneca in Q3 2013 and has held it in 15 quarters since.
Virtu KCG Holdings's AstraZeneca position peaked at $34.1M in Q4 2013.
465 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.